<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Clonal IgH gene rearrangement as a gene marker of B-cell <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e>, a new method of polymerase chain reaction amplification in conjunction with single-strand conformational polymorphism (PCR-SSCP) analysis was performed on the stored bone marrow slide specimens from patients with B cell <z:hpo ids='HP_0002664'>neoplasm</z:hpo> for detecting <z:e sem="disease" ids="C0242596" disease_type="Neoplastic Process" abbrv="MRD">minimal residual disease</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MRD</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>The method was sensitive to 1-2 malignant B-cells in 1,000 <z:mpath ids='MPATH_458'>normal</z:mpath> bone marrow cells </plain></SENT>
<SENT sid="2" pm="."><plain>In untreated patients with B-NHL, the incidence of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MRD</z:e> in bone marrow specimens was 68.4% (26/38) </plain></SENT>
<SENT sid="3" pm="."><plain>Patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MRD</z:e> in bone marrow had a shorter survival time than those without (P &lt; 0.05) </plain></SENT>
<SENT sid="4" pm="."><plain>In patients with <z:e sem="disease" ids="C0023435" disease_type="Neoplastic Process" abbrv="">B-ALL</z:e> in complete clinical remission, the incidence of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MRD</z:e> in bone marrow was 71.4% (15/21) </plain></SENT>
<SENT sid="5" pm="."><plain>There was a tendency of relapse in patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MRD</z:e> in bone marrow but persistent complete remission in patients without </plain></SENT>
<SENT sid="6" pm="."><plain>The results showed that detection of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MRD</z:e> in bone marrow may provide some important information for assessing prognosis and predicting relapse in patients with B-cell <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> </plain></SENT>
</text></document>